BackSihuan Pharmaceutical Holdings Group Overview

Sihuan Pharmaceutical Holdings Group Intangible Assets

Sihuan Pharmaceutical Holdings Group's intangible assets is $1B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$997.54M
↑ 10.96% YoYΔ $98.49M vs prior year quarter

Peer trimmed avg / median

Loading

Sihuan Pharmaceutical Holdings Group Intangible Assets History

Loading

Sihuan Pharmaceutical Holdings Group vs. peers: Intangible Assets Comparison

Loading

Sihuan Pharmaceutical Holdings Group Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Sihuan Pharmaceutical Holdings Group (SHPHF) FAQ

The latest intangible assets for SHPHF is $1B as of June 2026. That compares with $900M in the prior-year period — up 11.0% year over year. Investors often review this figure alongside Sihuan Pharmaceutical Holdings Group's historical trend and sector peers before judging valuation or financial health.

Over the past year, SHPHF's intangible assets moved from $900M to $1B — a 11.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sihuan Pharmaceutical Holdings Group's operating scale or balance-sheet position.

A intangible assets figure of $1B for SHPHF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SHPHF's intangible assets ($1B), review year-over-year change from $900M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.